Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles (CLOFA)

Fundació Privada Eugin

Status and phase: Completed; Phase 4

Conditions: Female Infertility

Treatments: Drug: Clomifene Citrate

Study type: Interventional

Funder types: Other

Identifiers

NCT01791751

CLOFA

2011-002173-33 (EudraCT Number)

Details and patient eligibility

About

The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.

Enrollment: 10 patients

Sex: Female

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Oocyte donors
• 18-35 years old
• BMI 18-29 Kg/m2
• Normal basal hormonal levels
• No contraceptive pill

Exclusion criteria

• Polycystic ovarian syndrome (PCOS)
• Previous participation in the study

Trial design

10 participants in 2 patient groups

Clomifene Citrate

Experimental group

Description:

Clomifene Citrate 50 mg

Treatment:

Drug: Clomifene Citrate

Control

No Intervention group

Description:

No intervention